Genomic Valley Biotech
BSE: GVBL INE574D01010
About Genomic Valley Biotech
Loading what this company does…
How the stock has moved
Genomic Valley Biotech (GVBL) closed at ₹55.67 on 4 Nov 2026, up 5.00% on the day. The share price rose 56.5% over the past year (adjusted for splits and bonuses) and trades at its 52-week high.
Not enough reported figures for a summary yet.
Worked out by Arthscan from the figures on this page, by fixed rules. A description of the data, not advice to buy or sell.
- Open
- 55.67
- Previous close
- 53.02
- Volume
- 4,536
- Value (₹ lakh)
- 2.52
- VWAP
- —
- Beta
- —
- Market cap (₹ Cr)
- —
- High
- 55.67
- Low
- 55.50
- Upper circuit
- —
- Lower circuit
- —
- 52-week high
- 55.67
- 52-week low
- 21.85
- Face value
- —
- All-time high
- —
- All-time low
- —
- 20-day avg volume
- 3,542
- Book value per share
- —
- Dividend yield
- —
- Debt to equity
- —
- TTM EPS
- —
- TTM P/E
- —
- P/B
- —
- Sector P/E
- —
- ROE
- —
- ROCE
- —
Session of 4 Nov 2026. Prices and limits from Dhan for BSE; ratios from Dhan and company filings.
Chart
Candles from Dhan, BSE prices, times in IST. Past prices are adjusted for splits and bonuses. Your drawings and settings stay in this browser.
Forecast
Technicals
52W breakout
Price & Volume
Returns
Volume
Seasonality
News
Financials
Source: Indian Stock API, from company filings. Annual columns are financial years; TTM is the trailing twelve months.